Find every first-time home buyer grant & down payment assistance program in the U.S.

The grant aims to support the Emerging Global Leader Program (K43) in alignment with clinical trials policy. Eligible applicants include non-domestic entities (foreign organizations) from low- and middle-income countries, as defined by the World Bank, with specific restrictions on upper-middle-income countries that are G20 members. Application details are not provided in the description, but interested parties can contact NIH Grants Information for further inquiries.

The grant aims to establish a National Center for Construction Safety and Health Research and Translation, focusing on multidisciplinary approaches to improve safety and health for construction workers in the U.S. Eligible applicants include government entities, small and for-profit businesses, nonprofits, and educational institutions. Specific application instructions are not provided, but interested parties can contact the program officer, Sharon Chiou, for more information.

The grant aims to provide funds for revision applications that support the expansion of existing projects or programs within the NIH awarding Institute or Center, as specified in a Notice of Special Interest (NOSI). Eligible applicants include various nonprofit organizations, educational institutions, government entities, and small businesses, among others. To apply, applicants must submit their applications in response to a relevant NOSI published by an NIH Institute or Center.

The grant aims to support R15-eligible Principal Investigators in conducting basic and mechanistic pain research, foster interdisciplinary partnerships, and enhance the research environment for health professional trainees and students. Eligible applicants include private and public institutions of higher education, as well as specific minority-serving institutions, while non-domestic entities are not eligible. Application details are not provided in the description; interested parties should refer to the full opportunity announcement for more information.

The grant aims to support multi-site exploratory and confirmatory clinical trials, biomarker validation studies, and ancillary studies related to stroke prevention, treatment, and recovery within the NIH StrokeNet framework. Eligible applicants include various government entities, educational institutions, nonprofits, and businesses, with specific provisions for organizations serving Native American populations and other minority groups. Application details are not explicitly provided in the description, but interested parties can contact NIH Grants Information for further inquiries.

The purpose of this grant is to support Exploratory/Developmental Research (R21) applications focused on the ethical, legal, and social implications (ELSI) of human genetics and genomics, particularly in relation to new genomic technologies. Eligible applicants include various government entities, for-profit and nonprofit organizations, educational institutions, and other specified groups such as tribal organizations and historically black colleges. Application details are not provided in the description, but interested parties can contact NIH Grants Information for further inquiries.

The grant aims to support applications that combine independent protocols for phase 1 clinical trials with phase 1b/phase 2a trials to facilitate the early evaluation of pharmacological interventions for Alzheimer's disease and related dementias, focusing on non-amyloid/non-tau mechanisms. Eligible applicants include independent school districts, public and private higher education institutions, various levels of government, nonprofits, and for-profit organizations, among others. To apply, interested parties should refer to the full opportunity announcement for specific application details and requirements.

The purpose of this grant is to support investigator-initiated clinical trials of complementary and integrative health approaches, specifically focusing on multisite feasibility trials that will inform future clinical efficacy studies. Eligible applicants include public and private higher education institutions, nonprofits, government entities, and for-profit organizations, among others. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions.

The purpose of this grant is to support Research Project (R01) applications that investigate the ethical, legal, and social implications (ELSI) of human genetics and genomics, encouraging diverse stakeholder involvement and requiring a Plan for Enhancing Diverse Perspectives (PEDP) in applications. Eligible applicants include various government entities, for-profit and nonprofit organizations, educational institutions, and other specified groups, including tribal organizations and minority-serving institutions. To apply, applicants must submit a proposal that includes the required PEDP, as applications lacking this component will not be reviewed.

The purpose of this grant is to support research focused on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD), specifically aiming to reduce prenatal alcohol exposure and improve interventions for those affected by FASD. Eligible applicants include various government entities, nonprofits, educational institutions, and for-profit organizations, including small businesses and tribal organizations. To apply, interested parties should refer to the full opportunity announcement for detailed application instructions and milestones for the R61/R33 phased award mechanism.

The purpose of this grant is to support feasibility trials of complementary and integrative health approaches for high-priority conditions identified by NCCIH, aiming to gather necessary data for planning future clinical trials. Eligible applicants include various government entities, small and for-profit businesses, educational institutions, nonprofits, and specific organizations serving diverse communities. Interested applicants are encouraged to contact the appropriate NCCIH Scientific/Research contact prior to submission for guidance on their planned application.

The grant aims to support investigator-initiated clinical trials that are fully remotely conducted to evaluate the efficacy of complementary and integrative health interventions in high-priority research areas. Eligible applicants include various nonprofit organizations, educational institutions, government entities, and small businesses, among others. To apply, interested parties are encouraged to contact the appropriate NCCIH Scientific/Research contact prior to submission and must provide justification for their remote approach along with preliminary data on feasibility and safety.